CytomX Therapeutics

New generation of fully recombinant, protease-activated monoclonal antibodies that can achieve unprecedented levels of tissue-specific targeting.

Get a Demo and See the Full Profile

Get a demo today to see profiles of CytomX Therapeutics plus 5959 other startups.

Learn More About CytomX Therapeutics

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More